Clinical Trial Update: TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing transarterial chemoembolization plus radiofrequency ablation versus TACE alone in intermediate-stage hepatocellular carcinoma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Radiofrequency ablation (RFA) (radiofrequency ablation)
• Transarterial chemoembolization (TACE)

Snippet

Sponsor: Ming Zhao | Conditions: Hepatocellular Carcinoma, Chemoembolization, Therapeutic | Phase 3 | Status: COMPLETED